Applications of nanotechnology in allergy and asthma
Journal of Basic & Clinical Medical Sciences · 2024
DOI: 10.58398/0002.000008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic & Clinical Medical Sciences, 2024. Verfasst von Saima Pervaiz und 5 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The increasing incidence of allergic diseases requires effective curative strategies for their alleviation. Allergen-specific immunotherapy (AIT) is a causal treatment technique instead of a symptomatic treatment technique for allergies. At present, AIT is being offered utilizing immunization response modifiers (IRMs) or adjuvants. The adjuvant helps in vigorous inaugral as well as long-term IR (immune response), thus enhancing the efficacy of AIT. The successful development of novel additives requires complete knowledge regarding the underdevelopment of novel and conservative additives. Hence, this review describes the applications of nanotechnology in allergic disorders, namely, allergies and asthma. The development of vaccines based on nanoparticles (NPs) is an important strategy for AIT because of their innate physicochemical characteristics, production ease and capacity to incite inherent immunity.
Zitieren
APA
Pervaiz, S., Cheema, S. M., Shaheen, T., Tahir, R., Haider, Z., & Shamim, S. (2024). Applications of nanotechnology in allergy and asthma. Journal of Basic & Clinical Medical Sciences. https://doi.org/10.58398/0002.000008
Vancouver
Pervaiz S, Cheema SM, Shaheen T, Tahir R, Haider Z, Shamim S. Applications of nanotechnology in allergy and asthma. Journal of Basic & Clinical Medical Sciences. 2024. doi:10.58398/0002.000008
BibTeX
@article{Pervaiz2024,
author = {Pervaiz, Saima and Cheema, Sara Masood and Shaheen, Tahir and Tahir, Romeeza and Haider, Zeeshan and Shamim, Saba},
title = {Applications of nanotechnology in allergy and asthma},
journal = {Journal of Basic & Clinical Medical Sciences},
year = {2024},
doi = {10.58398/0002.000008}
}
EUVIMED